Assessment of Feigned Cognitive Impairment A Neuropsychological Perspective

The go-to resource for clinical and forensic practice has now been significantly revised with 85% new material, reflecting the tremendous growth of the field. Leading authorities synthesize the state of the science on symptom feigning in cognitive testing and present evidence-based recommendations for distinguishing between credible and noncredible performance. A wide range of performance validity tests (PVTs) and symptom validity tests (SVTs) are critically reviewed and guidelines provided for applying them across differing cognitive domains and medical, neurological, and psychiatric conditions. The book also covers validity testing in forensic settings and with particular populations, such as ethnic and linguistic minority group members.

New to This Edition
*Numerous new authors, a greatly expanded range of topics, and the latest data throughout.
*"Clinical primer" chapter on how to select and interpret appropriate PVTs.
*Chapters on methods for validity testing in visual–spatial, processing speed, and language domains and with cognitive screening instruments and personality inventories.
*Chapter on methods for interpreting multiple PVTs in combination.
*Chapters on additional populations (military personnel, children and adolescents) and clinical problems (dementia, somatoform/conversion disorder).
*Chapters on research methods for validating PVTs, base rates of feigned mild traumatic brain injury, and more.

Kyle Brauer Boone, PhD, ABPP, ABCN, has a private practice in Torrance, California, and is Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles. She has published six books and over 125 peer-reviewed research articles, including many in the area of development and validation of tests to detect feigned cognitive symptoms. She has also published two tests used to assess for performance validity on neuropsychological exams: the b Test and the Dot Counting Test. Dr. Boone served on the committee that developed the practice guidelines for clinical neuropsychology published by the American Academy of Clinical Neuropsychology in 2007, and she was an invited attendee of the 25-member consensus conference that developed the practice guidelines for the use of neurocognitive performance validity tests published by the American Academy of Clinical Neuropsychology in 2009 and updated in 2021. She is board certified through the American Board of Clinical Neuropsychology, is a Fellow of the American Psychological Association, and is the 2020 recipient of the Ralph M. Reitan Award for Clinical Excellence from the National Academy of Neuropsychology.

I. Performance and Symptom Validity Tests
1. Clinician’s Guide to Navigating Performance Validity Testing, Maria E. Cottingham
2. Design Methods in Neuropsychological Performance Validity, Symptom Validity, and Malingering Research, Ryan W. Schroeder, Kyle Brauer Boone, & Glenn J. Larrabee
3. Forced-Choice Performance Validity Tests, Ryan W. Schroeder & Phillip K. Martin
4. Alternatives to Forced-Choice Performance Validity Tests, Stephen R. Nitch, Alexis S. Rosen, Laurel A. Mattos, Scott Roye, & David M. Glassmire
5. Intelligence Tests as Performance Validity Measures, Natalie Sobel, Talin Babikian, & Kyle Brauer Boone
6. Performance Validity Tests in Cognitive Screening Instruments and Computerized Assessment Tools, Patrick Armistead-Jehle & Robert D. Shura
7. Embedded Performance Validity Scores in Standard Memory Tests, Bradley N. Axelrod, Justin B. Miller, & Jennifer LaBuda
8. Validity Indicators within Executive Function Measures: Use and Limits in Detection of Response Validity, Nathaniel W. Nelson, Catherine Lee, & Jerry J. Sweet
9. Motor and Sensory Tests as Measures of Performance Validity, Ginger Arnold & Kyle Brauer Boone
10. The Use of Visual Spatial Performance Validity Tests in Detecting Noncredible Performance, Douglas M. Whiteside, Lauren E. Piper, Michael R. Basso, & Kyle Brauer Boone
11. Information Processing Speed Tests as Performance Validity Tests, Laszlo A. Erdodi & Jonathan D. Lichtenstein
12. Language Tests as Performance Validity Tests, Phillip K. Martin & Ryan W. Schroeder
13. Effects of Premorbid Ability, Neuropsychological Impairment, and Invalid Test Performance on the Frequency of Low Scores, Martin L. Rohling, Jennifer Langhinrichsen-Rohling, & John E. Meyers
14. Interpretation of Data from Multiple Performance Validity Tests, Jeremy J. Davis
15. Using the MMPI-2-RF as an Aid in the Detection of Noncredible Neurocognitive Presentations, Maria E. Cottingham, Kyle Brauer Boone, Hope E. Goldberg, Tara L. Victor, Michelle A. Zeller, Medina R. Baumgart, J. Brandon Birath, & Matthew J. Wright
16. Utility of the Personality Assessment Inventory in Evaluating Symptom Validity in the Context of Neuropsychological Evaluation, Owen J. Gaasedelen, Douglas M. Whiteside, & Kyle Brauer Boone
II. Use of Performance Validity Tests in Various Populations
17. Base Rates of Feigned Mild Traumatic Brain Injury, Kyle Brauer Boone, Pavel Litvin, & Tara L. Victor
18. Noncredible Presentations in Neuropsychological Assessment of Pain- and Fatigue-Related Disorders: Clinical and Research Implications, Julie A. Suhr & Andrew Bryant
19. The Impact of Psychotic, Depressive, Bipolar, Obsessive–Compulsive, and Anxiety Disorders on Performance Validity Test Results, Hope E. Goldberg & J. Brandon Birath
20. Performance Validity in Somatoform/Conversion Disorders, Factitious Disorder, and Malingering: Do We Need a New Diagnostic Schema?, Kyle Brauer Boone
21. Identification of Feigned Intellectual Disability, Tara L. Victor & Kyle Brauer Boone
22. Performance Validity Testing in Patients with Dementia, Kirsty E. Bortnik & Andy C. Dean
23. Performance Validity Tests in the Epilepsy Clinic, Daniel L. Drane, David J. Williamson, Kelsey Hewitt, & Taylor Jordan
24. Use of Performance Validity Tests and Symptom Validity Tests in Assessment of Specific Learning Disorders and Attention-Deficit/Hyperactivity Disorder, Allyson G. Harrison, Grace Jin Lee, & Julie A. Suhr
25. Toxic Mold Syndrome and Multiple Chemical Sensitivity: The Continued Search for a Causal Link to Neuropsychological Functioning, Robert J. McCaffrey & Julie K. Lynch
26. The Use of Performance Validity Tests in Ethnic-Minority and Non-English-Dominant Populations, Xavier F. Salazar, Po H. Lu, & Kyle Brauer Boone
27. Performance/Symptom Validity Test Use with Active Duty Service Members and Veterans, Patrick Armistead-Jehle, Douglas B. Cooper, Heather G. Belanger, Jason R. Soble, & Nathanial W. Nelson
28. Validity Assessment in Pediatric Populations, Alison M. Colbert, Emily C. Maxwell, & Michael W. Kirkwood
29. Assessment of Feigned Cognitive Impairment in Criminal Forensic Neuropsychological Settings, Robert L. Denney & Rachel L. Fazio
Index